drugset
Drugs / adipose-derived mesenchymal stem cells
last change Jan 2020 re-read 3 minutes ago

adipose-derived mesenchymal stem cells

also known as ADSC

Cell therapy

Developed for
cutis laxa · keloid
Investigated by
Medical University of Warsaw · Melitus sp. z o.o. · Polish Stem Cells Bank S.A. · Timeless Chirurgia Plastyczna-Janusz Jaworowski

Trials 1

today NCT03887208 · Ph 1/2
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT03887208 Jan 2018 → Jan 2020 cutis laxa, keloid Medical University of Warsaw Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as adipose-derived mesenchymal stem cells “human autologous adipose-derived mesenchymal stem cells (ADSC)” NCT03887208 ↗
Known as ADSC ClinicalTrials.gov intervention name — accepted as the source's own label NCT03887208 ↗
Modality Cell therapy “human autologous adipose-derived mesenchymal stem cells (ADSC)” NCT03887208 ↗
Route Subcutaneous “Subcutaneous injection of autologous ADSC” NCT03887208 ↗